Abnormal Corneal Lesions Induced by Trastuzumab Emtansine
Author:
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Ophthalmology
Reference10 articles.
1. Ocular adverse events associated with antibody-drug conjugates in human clinical trials;Eaton;J Ocul Pharmacol Ther,2015
2. Trastuzumab emtansine: a unique antibody-drug conjugate in development for human epidermal growth factor receptor 2-positive cancer;LoRusso;Clin Cancer Res,2011
3. Neoadjuvant treatment with trastuzumab in HER2-positive breast cancer: results from the GeparQuattro study;Untch;J Clin Oncol,2010
4. Phase II study of the antibody drug conjugate trastuzumab-DM1 for the treatment of human epidermal growth factor receptor 2 (HER2)-positive breast cancer after prior HER2-directed therapy;Burris;J Clin Oncol,2011
5. Expression of the receptor tyrosine kinases, epidermal growth factor receptor, ErbB2, and ErbB3, in human ocular surface epithelia;Liu;Cornea,2001
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ocular adverse events associated with antibody-drug conjugates in oncology: a pharmacovigilance study based on FDA adverse event reporting system (FAERS);Frontiers in Pharmacology;2024-08-20
2. Corneal Toxicity in Patients Treated by BELANTAMAB MAFODOTIN: How to Improve and Facilitate Patients Follow-Up Using Refractive Shift?;Journal of Ocular Pharmacology and Therapeutics;2024-07-08
3. Corneal ulcer development due to sintilimab-anlotinib combination therapy-induced dry eye: a case report;Translational Cancer Research;2024-05
4. Ocular Surface Side Effects of Novel Anticancer Drugs;Cancers;2024-01-13
5. Ocular toxicity associated with anti‐HER2 agents in breast cancer: A pharmacovigilance analysis using the FAERS database;International Journal of Cancer;2024-01-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3